These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 20938374

  • 1. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W.
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A, Monsonego J, Moyal-Barracco M, Pribil C.
    Ann Dermatol Venereol; 2003 Mar; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C.
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [Abstract] [Full Text] [Related]

  • 7. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA.
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New treatments for genital warts less than ideal: abstract and commentary.
    Fife KH.
    JAMA; 1998 Jun 24; 279(24):2003-4. PubMed ID: 9643868
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H, Van Ophoven A, Henke U, Lenz T, Eul A.
    Eur J Dermatol; 2006 Jun 24; 16(6):642-8. PubMed ID: 17229604
    [Abstract] [Full Text] [Related]

  • 18. [Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
    Gross G.
    Hautarzt; 2001 Jan 24; 52(1):6-17. PubMed ID: 11220242
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML, Bartlett BL, Tyring SK.
    Skin Therapy Lett; 2009 Jun 24; 14(5):1-3, 5. PubMed ID: 19609471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.